Rechercher des projets européens

Plus de 40 projets européens trouvés

Recherche sur 125080 projets européens

 TERMINÉ 

European Human Biomonitoring Initiative (HBM4EU)

Date du début: 1 janv. 2017, Date de fin: 31 déc. 2021,

The overarching goal of the European Human Biomonitoring Initiative (HBM4EU) is to generate knowledge to inform the safe management of chemicals and so protect human health. We will use human biomonitoring to understand human exposure to chemicals and resulting health impacts and will communicate with policy makers to ensure that our results are exploited in the design of new chemicals policies an ...
Voir le projet

 43

 TERMINÉ 
"HDHL-INTIMIC (INtesTInal MICrobiomics) is a proposal for an ERA-NET Cofund in the field of food, nutrition and health to support the Joint Programming Initiative "A Healthy Diet for a Healthy Life" (JPI HDHL).There is a high burden of non-communicable diseases due to unhealthy diet and lifestyle patterns. The intestine and in particular the intestinal microbiota have an influence on metabolic pr ...
Voir le projet

 14

 TERMINÉ 

ERA-NET ON NANOMEDICINE (EuroNanoMed III)

Date du début: 1 nov. 2016, Date de fin: 31 oct. 2021,

Nanomedicine is the application of nanotechnology to medicine and healthcare. The field takes advantage of the physical, chemical and biological properties of materials at the nanometer scale to be used for a better understanding of the biological mechanisms of diseases at the molecular level, leading to new targets for earlier and more precise diagnostics and therapeutics. Nanomedicine, rated amo ...
Voir le projet

 25

 TERMINÉ 
The main objectives of the 2nd Coordination and Support Action (CSA) of the Joint Programming Initiative Healthy Diet for a Healthy Life (JPI HDHL) are to support the further implementation of JPI HDHL and to create a sustainable collaboration of Member States (MS), the European Commission (EC) and related international organisations. Support facilitated by the 2nd CSA will ensure sufficient progr ...
Voir le projet

 11

 TERMINÉ 
ERA-HDHL is a proposal of ERA-NET Cofund in the field of nutrition and health to support the Joint Programme Initiative Healthy Diet for a Healthy Life (JPI HDHL).Nowadays, there is a high burden of non-communicable diseases due to unhealthy diet and lifestyle patterns. The 24 members of the JPI HDHL are working together to develop means to (1) motivate people to adopt healthier lifestyles includi ...
Voir le projet

 19

 TERMINÉ 
EXEDRA, an EXpansion of the European Joint Programming Initiative on Drug Resistance to Antimicrobials, will build on, and further support the structure and activities of JPIAMR to address the two major objectives of HCO-04-2016 topic: extending JPIAMR globally and creating a long-term sustainable structure for future expansion and governance which will coordinate national funding and collaborativ ...
Voir le projet

 15

 TERMINÉ 
The ERA-NET NEURON Cofund will coordinate and align European and international research funding programmes in the area of brain-related diseases and disorders of the nervous system. Key activity is the implementation of an EC co-funded joint transnational call for research proposals. The mission of NEURON is based on the fact that disorders of the brain are the major cause for impaired quality of ...
Voir le projet

 22

 TERMINÉ 
The potential of Personalised Medicine (PM) is to improve prevention, diagnosis and treatment of diseases by taking into account individuals' genotypes and phenotypes as well as other biomedical, life style and environmental data. In the last decade, significant advancements have been made especially for cancer or rare diseases. However, due to fragmentation and high upfront-investments the implem ...
Voir le projet

 4

 TERMINÉ 
Antibiotic resistance is a global problem. It is considered by the World Health Organization as one of the three greatest threats to human health for the next decades. ’Enhanced coordination across national boundaries is needed to accelerate the efforts to tackle this grand challenge. Such synergies have been created among 19 countries in Europe and beyond through the EU JPI on Antimicrobial Resis ...
Voir le projet

 19

 TERMINÉ 

European AIDS Vaccine Initiative 2020 (EAVI2020)

Date du début: 1 nov. 2015, Date de fin: 31 oct. 2020,

HIV-1 is responsible for a global pandemic of 35 million people, and continues to spread at a rate of >2 million new infections/year. It is widely acknowledged that a protective vaccine would be the most effective means to reduce HIV-1 spread and ultimately eliminate the pandemic, while a therapeutic vaccine may help mitigate the clinical course of disease and lead to strategies of viral eradicati ...
Voir le projet

 27

 TERMINÉ 
Cardiovascular diseases (CVD) are the largest cause of death in the EU and account for around 2 million deaths per year. Overall, CVD are estimated to cause the economy of the EU costs of almost 196 billion Euros a year. Furthermore, they are one of the leading causes of long term sickness, chronic diseases and loss to the labour market. Therefore, CVD are a major health problem in Europe. Despite ...
Voir le projet

 23

 TERMINÉ 

Integrated Climate forcing and Air pollution Reduction in Urban Systems (ICARUS)

Date du début: 1 mai 2016, Date de fin: 30 avr. 2020,

ICARUS will develop innovative tools for urban impact assessment in support of air quality and climate change governance in the EU. This will lead to designing and implementing win-win strategies to improve the air quality and reduce the carbon footprint in European cities. An integrated approach will be used for air pollution monitoring and assessment combining ground-based measurements, atmosphe ...
Voir le projet

 18

 TERMINÉ 
Systems medicine is a new approach which integrates biological and medical data with mathematical and computational modelling in order to understand the underlying mechanisms of disease and to develop new strategies for individualised diagnosis, treatment and prevention. Systems medicine can fill the gap between experimental data produced by modern technologies and medical knowledge. Through the i ...
Voir le projet

 15

 TERMINÉ 
Cancer is a worldwide health burden and represents a major public health challenge in Europe. It is responsible for 25% of all deaths, being the second most common cause of death after cardio-vascular diseases and the main cause of mortality among people aged 45–64. Today, an estimated 9 million individuals in Europe live with cancer (Globocan 2008, http://globocan.iarc.fr/). Cancer became a chron ...
Voir le projet

 30

 TERMINÉ 
Over 12 million people in Europe suffer from neurodegenerative diseases (ND), yet treatments that prevent or stop the progression of neurodegeneration are still lacking. Tackling this grand challenge requires enhanced coordination of national efforts to accelerate discovery. Such synergies have been created among 28 countries in the pilot EU JPI on Neurodegenerative Disease Research (JPND). JPND h ...
Voir le projet

 26

 TERMINÉ 
In order to strengthen the sustainability and resilience of health services and systems a unique consortium of governmental and funding organizations plus research institutes, has expressed the ambition to systematically learn from the organisation of care in other settings. Overall objective of TO-REACH is to provide groundwork for an ERA-NET that will contribute to the resilience, effectiveness, ...
Voir le projet

 31

 TERMINÉ 

ERA-NET rare disease research implementing IRDiRC objectives (E-Rare-3)

Date du début: 1 déc. 2014, Date de fin: 30 nov. 2019,

Rare diseases (RD) are diseases that affect not more than 5 per 10 000 persons (according to the EU definition). 7000 distinct rare diseases exist, affecting between 6% and 8% of the population (about 30 million EU citizens). The lack of specific health policies for rare diseases and the scarcity of the expertise, translate into delayed diagnosis, few medicinal products and difficult access to car ...
Voir le projet

 27

 TERMINÉ 
The overall aim of JPsustaiND is to support the development and extension of the capacities of the EU Joint Programming Initiative on Neurodegenerative Diseases, in particular Alzheimer's (JPND). Since 2009 JPND has been operating on a very light management structure based on a simple Terms of Reference. Through this JPND has been able to set a common Strategic Research Agenda, and to deliver its ...
Voir le projet

 16

 TERMINÉ 

Improving and professionalizing the Health NCP service across Europe. (HNN 2.0)

Date du début: 1 déc. 2014, Date de fin: 30 nov. 2018,

Health NCP Net 2.0 aims at improving and professionalizing the NCP service, thus achieving a more consistent level of NCP support services across Europe with the final goal to better support applicants and raise the average quality of proposals submitted. HNN 2.0 builds upon the experience and results of the previous Health NCP Net project with the objective of responding to the new challenges tha ...
Voir le projet

 13

 TERMINÉ 
Despite examples of excellent practice, rare disease (RD) research is still mainly fragmented by data and disease types. Individual efforts have little interoperability and almost no systematic connection between detailed clinical and genetic information, biomaterial availability or research/trial datasets. By developing robust mechanisms and standards for linking and exploiting these data, RD-Con ...
Voir le projet

 30

 TERMINÉ 
The I-MOVE+ Consortium includes European Union (EU) Public Health Institutes, SME and Universities. It aims at measuring and comparing the effectiveness (VE) and impact (VI) of influenza and Pneumococcal vaccines and vaccination strategies a in the elderly population in Europe. The goal is to develop a sustainable platform of primary care practices, hospitals and laboratory networks that share val ...
Voir le projet

 33

 TERMINÉ 
The World Health Organisation in its report on Neglected Tropical Diseases has stated that there is overwhelming evidence to show that the burden caused by many of the 17 diseases that affect more than 1billion people worldwide can be effectively controlled and, in many cases, eliminated or even eradicated. Leishmaniasis caused by Leishmania spp is one of them and poses a grave health risk to an e ...
Voir le projet

 9

 TERMINÉ 
J-AGEII, the Coordination Action for implementation and alignment activities of the Joint Programming Initiative (JPI) 'More Years Better Lives – the Challenges and Opportunities of Demographic Change', will support and foster the overall management of the JPI, update the Strategic Research Agenda and support implementation through joint activities between Member States. Furthermore, the work plan ...
Voir le projet

 10

 TERMINÉ 

Euro-BioImaging Preparatory Phase II - Project (EuBI PPII)

Date du début: 1 janv. 2016, Date de fin: 31 déc. 2017,

Euro-BioImaging (EuBI) is the pan-European research infrastructure project for imaging technologies in biological and medical sciences and has been on the ESFRI Roadmap since 2008. In close match with the scope and objectives of the INFRADEV2 call, Preparatory Phase II (PPII) funding will enable EuBI:• to finalize the submission and approval procedure of its ERIC statutes with the EC and bring the ...
Voir le projet

 21

 TERMINÉ 

National Contact Points for quality standards and horizontal issues (NCP ACADEMY)

Date du début: 10 déc. 2014, Date de fin: 9 déc. 2017,

National Contact Points (NCPs) will play a key role in Horizon 2020 as providers of information and assistance to potential applicants and project beneficiaries. They constitute the main interface to the European R&D community for Member States and Associated Countries and the European Commission. While their activities are underpinned by the European Commission’s “Guiding principles for setting u ...
Voir le projet

 16

 TERMINÉ 

European Research Infrastructures for Poverty Related Diseases (EURIPRED)

Date du début: 1 nov. 2013, Date de fin: 31 oct. 2017,

HIV/AIDS, Tuberculosis (TB) and Malaria alone account for more than six million deaths worldwide every year. Despite substantial efforts made in recent years, Poverty Related Diseases are still spreading. New therapeutic interventions are therefore urgently required to combat Poverty Related Diseases. The existence of a well-developed HIV/TB/Malaria infrastructure presents a prime opportunity to a ...
Voir le projet

 18

 TERMINÉ 
SATORI is a 45-month project, comprising 17 partners from 13 countries, including an intergovernmental organisation, the aim of which is to improve respect of ethics principles and laws in research and innovation, and to make sure that they are adequately adapted to the evolution of technologies and societal concerns. The partners will develop an ethics assessment framework based on thorough analy ...
Voir le projet

 19

 TERMINÉ 
The EU-LAC Health coordinating action proposes to define a detailed plan to guide policy makers and other stakeholders on future actions to support cooperative Health Research between Latin America and Caribbean countries (LAC) and the European Commission and Member States (EU). This consensus Roadmap will be developed using a policy oriented approach and taking into account the new political fram ...
Voir le projet

 10

 TERMINÉ 

European Research Infrastructure on Highly Pathogenic Agents 2 (ERINHA2)

Date du début: 1 janv. 2016, Date de fin: 30 juin 2017,

ERINHA2 aims to complete the work carried out during the first preparatory phase (PP1) - ERINHA - in order to reach the financial, administrative and technical maturity necessary to complete the establishment of the Research Infrastructre and ensure that the operation phase can begin in 2018. ERINHA2 will therefore finalise the decision to use the status of an association and prepare the necessary ...
Voir le projet

 17

 TERMINÉ 

Sustainable Technology for Older People – Get Organised (STOPandGO)

Date du début: 1 avr. 2014, Date de fin: 31 mars 2017,

Description The rapidly ageing population across the EU is placing relentless pressure on increasingly scarce health and social care resources. More people live with multiple co-morbidities, and there are fewer people to care for them. The Whole System Demonstrator (WSD) showed that incorporating telehealth and telecare technology into care ...
Voir le projet

 15

 TERMINÉ 

European Bank for induced pluripotent Stem Cells (EBISC)

Date du début: 1 janv. 2014, Date de fin: 31 déc. 2016,

EBiSC is designed to address the increasing demand by iPSC researchers for quality-controlled, disease-relevant research grade iPSC lines, data and cell services. Its goal is to demonstrate an operational banking and distribution service of iPSC lines after 3 years and to establish subsequently for Europe a centralised, not-for-profit bank providing all qualified users with access to scalable, cos ...
Voir le projet

 30

 TERMINÉ 

Coordination of European funding for infectious diseases research (Infect-ERA)

Date du début: 1 janv. 2013, Date de fin: 31 déc. 2016,

Infectious diseases (ID) also known as communicable diseases are one of the majorcauses of death worldwide. Every year in Europe, infectious diseases cause tens of thousands of deaths (from ECDC ‘Microbes without borders: key facts on infectious diseases in Europe’ 2007 report).In order to address the challenges in ID and design adapted treatments, as well as diagnostic and preventive tools, the f ...
Voir le projet

 19

 TERMINÉ 
RARE-Bestpractices will develop a sustainable networking platform, supporting the collection of standardized and validated data and efficient exchange of knowledge and reliable information on rare diseases (RD).RD are characterized by low prevalence (EU – 5:10000 persons). There are more than 5000, overall affecting about 30 million citizens of all ages in the EU. RD are often life-threatening and ...
Voir le projet

 16

 TERMINÉ 
Nanomedicine, the application of nanotechnology to health, is a fast-growing field with a large potential for improving diagnostics and therapeutic solutions in many diseases. The EuroNanoMed II (ENM II) consortium, with 20 partners from 17 countries and regions, aims to foster the competitiveness of European nanomedicine actors through the support of translational research projects enhancing tran ...
Voir le projet

 25

 TERMINÉ 
Current surveillance systems and control efforts are clearly insufficient to combat dengue in endemic countries and to prevent spread to previously uninfected areas (including Europe). We will focus on the following aspects of the call: better diagnosis, surveillance, prevention as well as prediction and/or prevention of the spread of Dengue fever to previously uninfected regions (including Europe ...
Voir le projet

 14

 TERMINÉ 

Prevention of Falls Network for Dissemination (ProFouND)

Date du début: 1 mars 2013, Date de fin: 29 févr. 2016,

Description The Prevention of Falls Network for Dissemination (ProFouND) is a thematic network working with the European Innovation Partnership on Active and Healthy Ageing to bring about the dissemination and implementation of best practice in falls prevention across Europe. ProFouND comprises 21 partners from 12 countries, with associate m ...
Voir le projet

 22

 TERMINÉ 
This Coordination and Support Action proposal aims at aiding the implementation of the Joint Programming Initiative on Antimicrobial Resistance (JPIAMR). JPIAMR currently has 18 participating countries and organisations from 8 of these are active partners of the CSA consortium. This proposal describes in detail the different work packages (WPs) that have been suggested in order to secure the rapid ...
Voir le projet

 11

 TERMINÉ 
The EUBrazilCC project is a first step towards providing a user-centric, cross-Atlantic test bench for European & Brazilian research communities. EUBrazilCC is centred in practical scientific use cases, and it is built on a close collaboration among European & Brazilian excellence centres. EUBrazilCC will exploit & coordinate, in a 2 year project, existing heterogeneous e-Infrastructures (virtuali ...
Voir le projet

 7

 TERMINÉ 

ERASysAPP - Systems Biology Applications (ERASYSAPP)

Date du début: 1 janv. 2013, Date de fin: 31 déc. 2015,

The main objective of the ERANET proposal “Systems Biology Applications – ERASysAPP” (app = application = translational systems biology) is to promote multidimensional and complementary European systems biology projects, programmes, and research initiatives on a number of selected research topics. Inter alia, ERASysAPP will initiate, execute and monitor a number of joint transnational calls on sys ...
Voir le projet

 19

 TERMINÉ 
Over the past 15 years, EU-funded cohorts and collaborations (EuroSIDA, CASCADE and PENTA), have played a central role in developing our understanding of HIV progression and the effects of ART, enabling European expertise to contribute directly to the advances in patient diagnosis and management worldwide, and providing a continued surveillance mechanism for detection of emerging problems at a Eur ...
Voir le projet

 26